Stockholders' Equity Attributable to Parent in USD of Celularity Inc from Q3 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
Summary
Celularity Inc quarterly Stockholders' Equity Attributable to Parent history and change rate from Q3 2018 to Q3 2025.
  • Celularity Inc Stockholders' Equity Attributable to Parent for the quarter ending 30 Sep 2025 was -$20.1M, a 216% decline year-over-year.
Stockholders' Equity Attributable to Parent, Quarterly (USD)
Stockholders' Equity Attributable to Parent, YoY Quarterly Change (%)

Celularity Inc Quarterly Stockholders' Equity Attributable to Parent (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 -$20.1M -$37.4M -216% 30 Sep 2025 10-Q 14 Nov 2025
Q2 2025 -$25.5M -$53.3M -192% 30 Jun 2025 10-Q 14 Nov 2025
Q1 2025 -$5.51M -$36.8M -118% 31 Mar 2025 10-Q 14 Nov 2025
Q4 2024 $8.84M -$32.1M -78.4% 31 Dec 2024 10-Q 14 Nov 2025
Q3 2024 $17.3M -$13M -42.9% 30 Sep 2024 10-Q 14 Nov 2025
Q2 2024 $27.8M -$90.7M -76.5% 30 Jun 2024 10-Q 14 Nov 2025
Q1 2024 $31.2M -$124M -79.9% 31 Mar 2024 10-Q 14 Nov 2025
Q4 2023 $41M -$158M -79.4% 31 Dec 2023 10-Q 14 Nov 2025
Q3 2023 $30.2M -$134M -81.6% 30 Sep 2023 10-Q 06 Dec 2024
Q2 2023 $119M -$31.6M -21.1% 30 Jun 2023 10-Q 06 Dec 2024
Q1 2023 $156M +$65.7M +73.1% 31 Mar 2023 10-Q 06 Dec 2024
Q4 2022 $199M +$99.5M +100% 31 Dec 2022 10-K 08 May 2025
Q3 2022 $164M +$68M +70.7% 30 Sep 2022 10-Q 03 Jan 2024
Q2 2022 $150M +$798M 30 Jun 2022 10-Q 03 Jan 2024
Q1 2022 $89.9M +$702M 31 Mar 2022 10-Q 03 Jan 2024
Q4 2021 $99.4M +$631M 31 Dec 2021 10-K 30 Jul 2024
Q3 2021 $96.2M +$633M 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 -$648M -$157M -32% 30 Jun 2021 10-Q 10 Nov 2022
Q1 2021 -$612M -$255M -71.5% 31 Mar 2021 10-Q 10 Nov 2022
Q4 2020 -$531M -$204M -62.3% 31 Dec 2020 10-K 31 Mar 2023
Q3 2020 -$536M -$541M -10828% 30 Sep 2020 10-Q 12 Nov 2021
Q2 2020 -$491M -$496M -9919% 30 Jun 2020 10-Q 12 Nov 2021
Q1 2020 -$357M -$357M 31 Mar 2020 10-Q 12 Nov 2021
Q4 2019 -$327M -$327M 31 Dec 2019 10-K 31 Mar 2022
Q3 2019 $5M +$4.98M 30 Sep 2019 10-Q 16 Nov 2020
Q2 2019 $5M 30 Jun 2019 10-Q 16 Nov 2020
Q1 2019 $23.8K* 31 Mar 2019 10-Q 16 Nov 2020
Q4 2018 $23.9K* 31 Dec 2018 10-K/A 24 May 2021
Q3 2018 $24.5K* 30 Sep 2018 10-Q 13 Nov 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.